Target intelligence / Profile preview

Ebola virus VP35 mRNA (VP35 mRNA)

Target
VP35 mRNA
Molecular classification
Messenger RNA, Viral nucleic acid
01

Overview

Ebola virus VP35 mRNA is the messenger RNA transcript responsible for the production of the VP35 protein in Zaire ebolavirus. The encoded VP35 protein is a multifunctional component of the viral polymerase complex, acting as a critical cofactor for the viral RNA-dependent RNA polymerase (L protein) and playing a major role in viral nucleocapsid assembly. Beyond its structural and replicative roles, VP35 is a potent interferon (IFN) antagonist that suppresses the host's innate immune response by blocking the activation of RIG-I-like receptors and inhibiting the phosphorylation of IRF-3/IRF-7. Because VP35 is essential for both viral replication and the evasion of host immunity, its mRNA has been utilized as a therapeutic target for RNA interference (RNAi) technologies. Drugs like TKM-Ebola employ lipid nanoparticles to deliver siRNAs that specifically bind to and trigger the degradation of VP35 mRNA, thereby halting the production of the protein and inhibiting the progression of Ebola virus disease.

Other names
Zaire ebolavirus VP35 mRNAEBOV VP35 mRNAPolymerase cofactor VP35 mRNAInterferon antagonist VP35 mRNA
02

Mechanism of action

RNA interference (RNAi) mediated degradation of viral mRNA via small interfering RNAs (siRNAs) delivered in lipid nanoparticles, preventing the translation of the VP35 protein.

03

Biological functions

Viral replicationImmune evasionInterferon signaling inhibitionViral assemblyRNA synthesis
04

Disease associations

InfectionEbola virus diseaseHemorrhagic fever
05

Safety considerations

Infusion-related reactionsCytokine release syndromeOff-target RNAi effectsLipid nanoparticle-associated toxicityRapid viral mutation leading to resistance
06

Interacting drugs

TKM-Ebola (TKM-100802)

1 more in the full profile.

07

Biomarkers

Ebola virus RNA titer (RT-PCR)VP35 protein levelsSerum cytokine levelsAlanine aminotransferase (ALT) levels

Beyond the preview

Go deeper on Ebola virus VP35 mRNA (VP35 mRNA).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ebola virus VP35 mRNA (VP35 mRNA).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call